Selank
2 RCTsEmerging
| Anxiolytic effect reported in Russian clinical studies | partially true |
| A non-sedating replacement for prescribed treatment | weak evidence |
Goal matrix
Every compound we track for this goal.
| Anxiolytic effect reported in Russian clinical studies | partially true |
| A non-sedating replacement for prescribed treatment | weak evidence |
| Used clinically in Russia for stroke and cognitive indications | supported |
| Raises BDNF and neuroplasticity | preclinical only |
| Enhances cognition in healthy adults | weak evidence |
| Antidepressant-like effects in rodents | animal data only |
| A validated treatment for depression | overreach |
| Promotes neurogenesis in animal models | animal data only |
| Improves human memory and learning | overreach |
All content on Peptuity is provided for research and educational purposes only. Peptuity does not sell, distribute, or facilitate the purchase of any compound, does not provide medical advice, and makes no claims regarding safety or efficacy. Most compounds discussed are not approved for human use by the SFDA or FDA. Always consult a qualified physician.